Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Jodhpur AIIMS purchased additional material worth Rs 2.32 crore during Covid

Jodhpur : Jodhpur During the Corona epidemic, where people were yearning for one Remdesivir injection, a large quantity of Remdesivir injections were purchased in AIIMS Jodhpur. Of these, 2449 injections worth Rs 57,36,800 expired due to not being used. The investigation found that AIIMS had made irregular purchases in excess of the requirement. There were 3567 injections available at AIIMS at the beginning of May 2021. Despite this, 1080, 1520 and 1341 injections were purchased from different companies on May 18, May 21 and May 25 respectively. After checking the stock, 5 thousand 949 Remdesivir injections were left. Out of this, maximum 3500 free of cost injections turned out to be unexpired. The remaining injections 2449 expired due to expiry.

In CAG investigation, medicines worth more than Rs 87 lakh had expired. Apart from this, in other checks of the stock register, other consumables were purchased during October 2018 to June 2020. Investigation revealed that goods worth Rs 2.32 crore were remaining. In its reply to CAG, AIIMS said that due to the Corona epidemic, all types of operation theaters were not in operation except in emergency situations, hence this material could not be used. CAG did not seem satisfied here either. CAG says that the Corona epidemic spread in March 2020, while some material was purchased one and a half years before that, some material was also purchased in April 2020 and June 2020, at that time the Corona epidemic was at its peak. It is clear from this that funds were blocked by purchasing material without actual assessment and requirement.

AIIMS had enough injections, yet bought more

When CAG sought a reply in this regard, AIIMS argued that these injections could not be used due to the huge decline in patients of the Covid pandemic during the year 2021-22. CAG AIIMS seemed dissatisfied with this. The CAG said the injections were procured despite there being sufficient quantity. Their expiry dates were April 2022 and October 2022. Due to improper use of medicines, there was a loss of Rs 57,36,800 lakh.

Leave a Comment

Internet services in Bangladesh will remain disrupted on December 2
Read more

Read Next